Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Alamar Biosciences, Inc.NASDAQ: ALMR

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables of $6.32M in Q2 FY2026

Q2 FY2026 accounts payables was $6.32M.

Context

  • Accounts payables amounted to 0.8% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$6.32M+371.9% QoQ
Last fiscal yearDec 2025
-$572K— YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(572K) USD
Year-over-year change
—

Accounts Payables vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 accounts payables of $572K is the 5th largest of the 9 companies compared; the peer median is $127.5K.
  • Accounts payables amounts to 0.8% of revenue for ALMR, versus a peer median of 0.7%.
ALMR Competitors Peer median
Accounts Payables for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TECHBio-Techne CorporationLTM Sep 2026$24.54M +575.7%—2.0%
TWSTTwist Bioscience CorporationLTM Sep 2026$13.93M +49.2%—3.0%
TXG10x Genomics, Inc.LTM Jun 2026$2.46M +144.1%—0.4%
SEERSeer, Inc.LTM Mar 2026$1.93M -198.4%—12.8%
ALMRAlamar Biosciences, Inc.FY2025$572K ——0.8%
LABStandard BioTools Inc.LTM Mar 2026$571K -82.0%—0.7%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$315K -95.3%+34.3%0.2%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$262K +132.6%-50.3%—
QSIQuantum-Si incorporatedLTM Mar 2026$7K -100.7%—0.4%
Peer median (excluding ALMR) $127.5K-16.4%-8.0%0.7%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.